Indrayani Biotech Ltd
₹8.08
(-1.10%)
Wed, 04 Mar 2026, 03:55 pm
Consumer Services
Restaurants
24.5KIndrayani Biotech Return on Equity (ROE) History
| Particulars | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.77 | 0 | 23.51 | 16.21 | 21.48 | 0 |
| Price to book ratio | 0 | 0 | 4.18 | 4.20 | 4.31 | 4.40 | 4.53 | 0.62 | 0.57 | 0 | 0 | 0.10 | 1.10 | 4.32 | 3.51 | 3.33 | 0.90 |
| Price to sales ratio | 3.76 | 8.60 | 0.38 | 0.25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.06 | 1.05 | 1.70 | 1.19 | 1.35 | 0.50 |
| Price to cash flow ratio | 0 | 0 | 17.02 | 10.89 | 223.97 | 0 | 0 | 0 | 0 | 0 | 0 | 0.63 | 0 | 0 | 0 | 0 | 0 |
| Enterprise value | 8.6M | 17.14M | 167.56M | 154.13M | 148.36M | 149.02M | 149.93M | 23.08M | 21.85M | 26.88M | 31.87M | 153.82M | 369.51M | 1.22B | 2.55B | 3.45B | 2.29B |
| Enterprise value to EBITDA ratio | 0 | 0 | 18.66 | 20.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.53 | 0 | 18 | 14.75 | 14.58 | 35.51 |
| Debt to equity ratio | 0 | 0 | 0.62 | 0.53 | 0.04 | 0.04 | 0.08 | 0.13 | 0.16 | 0 | 0 | 0.45 | 0.79 | 0.78 | 1.30 | 1.67 | 1.89 |
| Return on equity % | 0 | 0 | -3.12 | -1.84 | -0.18 | -2.06 | -3.06 | -4.05 | -7.84 | -10.24 | 0 | 5.35 | -117.94 | 20.23 | 30.11 | 17.04 | -8.74 |
Indrayani Biotech Ltd Return on Equity
The Indrayani Biotech Ltd Return on Equity is a key financial metric used by investors to evaluate Indrayani Biotech Ltd's valuation, profitability, and overall financial performance. Tracking the Indrayani Biotech Ltd Return on Equity helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Indrayani Biotech Ltd (NSE: , BSE: 526445) is currently trading at ₹8.08, with a market capitalization of ₹367.93M. As a leading company in the Consumer services sector and Restaurants industry, monitoring the Indrayani Biotech Ltd Return on Equity is essential for fundamental analysis.
Indrayani Biotech Ltd Return on Equity Current Value
The current Indrayani Biotech Ltd Return on Equity stands at -8.74.
The Indrayani Biotech Ltd Return on Equity has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Indrayani Biotech Ltd Return on Equity Historical Trend
The Indrayani Biotech Ltd Return on Equity has shown the following historical trend:
- 2024: -8.74
- 2023: 17.04
- 2022: 30.11
- 2021: 20.23
- 2020: -117.94
The decline in Indrayani Biotech Ltd Return on Equity indicates improving financial efficiency or better earnings growth.
What Indrayani Biotech Ltd Return on Equity Indicates for Investors
The Indrayani Biotech Ltd Return on Equity plays a crucial role in understanding the company's financial health and valuation.
ROE indicates how efficiently the company generates returns for shareholders.
Indrayani Biotech Ltd Return on Equity Analysis Summary
The Indrayani Biotech Ltd Return on Equity remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Indrayani Biotech Ltd Return on Equity should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Indrayani Biotech Ltd Return on Equity helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800